Influence of the "Hypotension Probability Index" on Intraoperative and Postoperative Hypotension in ENT- and OM-Surgery

Sponsor
University of Giessen (Other)
Overall Status
Recruiting
CT.gov ID
NCT04151264
Collaborator
Edwards Lifesciences (Industry)
50
1
2
30.1
1.7

Study Details

Study Description

Brief Summary

The aim of the project is to investigate whether the use of the HPI can reduce the number and duration of intra- and postoperative hypotension in ventilated patients during and two hours after extensive surgery in the head and neck area compared to the established monitoring.

Condition or Disease Intervention/Treatment Phase
  • Device: Hypotension probability index (HPI)
N/A

Detailed Description

Blood pressure monitoring displays a crucial part of anesthetic management. An intraoperative hypotension (IOH) is an unwanted complication that can occur during an anaesthetization or during the following duration of the surgery. Causes for this can be vasodilatation (e.g. due to medication), loss of blood volume (e.g. bleeding) or lack of inotropy (reduced left ventricular function, e.g. due to medication).

The main high-risk factors for intraoperative hypotension are age of the patient, pre-existing diseases (especially ASA 3 and higher), the duration of surgery, the urgency of the surgery (emergency surgery), antihypertensive long-term medication as well as combined anaesthesia (regional and general anaesthesia).

According to the examined collective, the definition of IOH and the level of training of the performing doctor we can monitor IOH in up to 100% of patients (depending on the data collection). Monk et al. show that the one-year mortality of patients undergoing surgery was elevated to 3.6% for every minute the systolic pressure was less than 80mmHg. Also, the risk of mortality was 1.4 higher if the MAP decreased <55mmHg. The consequence of IOH can be a critical reduction of the oxygen supply in the organs. Therefore, organs with low tolerance for hypoxia or a high necessity for oxygen are prone to hypotension induced complications. Those include ischemic stroke or myocardial ischemia (especially in patients with preexisting anemia), mostly happening to older or critical ill patients.

The extensive surgeries in ENT- and OM surgery are usually due to tumor diseases. The incidence for hypopharynx carcinoma is between 2-3/10.000 cases each year with an increasing tendency. The peak of this disease is in the 5.-6. decade of life. Causes for this are chronic noxae like alcohol and cigarettes. Numbers show, that the percentage of malignant tumors in the oral cavity and the pharynx in Germany in 2012 were at 3.7% with men and 1.6% with women in the entirety of incidence of malignant tumors. Especially these tumors require a radical resection also in the initial state of the disease which comes along with a long duration of surgery. The operative interventions include a radical resection of the tumor, neck dissection and if necessary a skin flap depending on the state of the tumor, TNM classification and status of lymph nodes. Complications that can occur with these types of surgery are (secondary) bleeding, stenosis, dyspnea, oedema of the mucosa, subcutaneous emphysema, dysphagia and aspiration. Because of the surgical treatment these patients require a postoperative sedation and ventilation. This enables the protection of the respiratory system when patients are at high risk for intra- or postoperative secondary bleeding and/or swelling. Also, the sedation will help not to imperil the success of the intervention (e.g. through coughing, pressure or choking).

The Hypotension Prediction Index (HPI) was developed by Edwards Lifesciences (Irvine, California, USA) and is certified in the US and Europe. As part of the Edwards Acumen Decision Support software suite, the HPI is based on the minimal invasive FloTrac IQ sensor. The HPI indicates the probability of an occurring hypotensive event. The software was developed using 20,000 cases of past patient events. If the upper limit of hypotension is reached, the software will alert the responsible physician.

The main outcome criteria are the numbers (n) and duration in minutes (t [min]) of intraoperative and postoperative hypotension. These are defined as MAP below 65 mmHg for more than one minute in ventilated patients with and without the use of HPI.

The secondary objective criteria are the following:
  • Assumed reason for hypotension

  • Amount of applied infusion volume (crystalloids, colloids, blood products and blood)

  • Type and dose of applied vasopressors

  • Type and dose of applied inotropic agents

  • Acute Kidney Injury Risk Score

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized two arm study with two groups.Randomized two arm study with two groups.
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Influence of the "Hypotension Probability Index" on the Number and Duration of Intraoperative and Postoperative Hypotension During Extended Surgical Procedures in ENT- and OM-Surgery
Actual Study Start Date :
May 30, 2020
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control Arm

blinded HPI monitoring

Active Comparator: Intervention Arm

HPI monitoring to predict hypotension

Device: Hypotension probability index (HPI)
The intervention group is managed with the HPI parameter to detect and possibly prevent hypotension during anaesthesia.

Outcome Measures

Primary Outcome Measures

  1. number (n) of intraoperative and postoperative hypotension [until 4 hours after the end of surgery]

    MAP below 65 mmHg for more than one minute in ventilated patients

Secondary Outcome Measures

  1. Applied volume in ml [until 4 hours after the end of surgery]

    Amount of applied infusion volume (crystalloids, colloids, blood products and blood) in ml

  2. Changes of catecholamine management [until 4 hours after the end of surgery]

    Dosage of vasopressors and inotropes (in μg)

  3. Duration of surgery [up to 24 hours]

    cut-seam time

  4. Fluid balance [until 4 hours after the end of surgery]

    blood loss and urin output in ml

  5. Hospital length of stay [up to 18 month]

    Duration of stay in hospital

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • extensive surgery in the head and neck area

  • Age ≥ 18 years

Exclusion Criteria:
  • Participation in another interventional study

  • Pregnancy and nursing mothers

  • Surgery without controlled ventilation

  • Contraindication to invasive arterial pressure measurement

  • Renal insufficiency KDIGO stage ≥ 3

  • Congenital coagulation disorder

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Clinic Giessen Gießen Hessen Germany 35392

Sponsors and Collaborators

  • University of Giessen
  • Edwards Lifesciences

Investigators

  • Study Director: Michael Sander, Prof., UKGM Giessen

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
University of Giessen
ClinicalTrials.gov Identifier:
NCT04151264
Other Study ID Numbers:
  • HPI II
First Posted:
Nov 5, 2019
Last Update Posted:
Nov 5, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Giessen
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 5, 2021